In India private equity has poured billions into tech startups, infrastructure, and consumer brands. But there’s one sector that keeps pulling investors back healthcare. And while the usual reasons like rising demand, a massive population, and economic growth are obvious, those aren’t the most interesting reasons why PE firms love this space.
For starters, healthcare in India isn’t just about hospitals anymore. Investors have cracked the code that owning a hospital is not the only way to profit from healthcare. The real money is in the ecosystem that supports it diagnostics, specialty clinics, surgical centers, pharma supply chains, insurance innovations, and digital health platforms. The hospital itself is just one piece of a much bigger puzzle. A PE-backed fund doesn’t need to own an Apollo or a Fortis to make money in healthcare anymore. Instead, it can fund a high-margin IVF chain, a tech-driven pathology business, or an AI-powered radiology network and see exponential returns .
Then there’s the predictability of healthcare cash flows. Unlike consumer businesses, where demand fluctuates based on trends, healthcare is non-discretionary. People don’t decide whether to get an MRI or a kidney transplant based on market conditions. The need is always there. And with India’s out-of-pocket healthcare expenditure still among the highest in the world, patients often pay upfront, making healthcare businesses cash-flow positive and attractive to PE investors .
What’s also fascinating is how Tier 2 and 3 cities are driving profitability. PE firms once saw these markets as underdeveloped, but that’s changed dramatically. The fastest-growing hospital chains today aren’t adding beds in Mumbai and Delhi, they’re expanding into Indore, Nagpur, and Coimbatore. Patients from these cities were already traveling to metros for treatment; now they don’t have to. Mid-sized specialty chains are scaling without the insane real estate costs of metros, and PE firms are backing them to expand aggressively .
The rise of single-specialty chains has also caught PE’s attention. Instead of funding massive hospitals that treat everything, PE is betting on hyper-focused brands. Oncology clinics, IVF centers, orthopedic surgery chains, these businesses operate like highly efficient machines, keeping overhead low and profit margins high. A cardiology hospital doesn’t need to invest in neurosurgeons or pediatrics, which means it can maximize efficiency and scale faster. That’s the kind of operational model PE investors love .
And let’s not forget regulatory tailwinds. While Indian healthcare has its share of bureaucratic hurdles, the government’s focus on health insurance penetration, Ayushman Bharat, and increased FDI in healthcare infrastructure means the overall environment is far more investor-friendly than it was a decade ago. Private investors aren’t fighting the system anymore; they’re growing alongside it .
So, why does PE love Indian healthcare? Because it’s no longer just about the massive demand, it’s about business models that work, exits that are visible, and a market that is still massively underserved.
Source – EY The AIdea of India 2025 – How Much Productivity Can GenAI Unlock in India
TERMS OF USE
Thank you for your interest in our Website at https://unlistedintel.com/. Your use of this Website, including the content, materials and information available on or through this Website (together, the “Materials”), is governed by these Terms of Use (these “Terms”). By using this Website, you acknowledge that you have read and agree to these Terms.
NO OFFER, SOLICITATION OR ADVICE
Our site is provided for informational purposes only. It does not constitute to constitute (i) an offer, or solicitation of an offer, to
purchase or sell any security, other assets, or service, (ii) investment, legal, business, or tax advice, or an offer to provide such advice or (iii) a basis for making any investment decision.
The Materials are provided for informational purposes and have been prepared by Oister Global for informational purposes to acquaint existing and prospective underlying funds, entrepreneurs, and other company founders with Oister Global's recent and historical investment activities.
Please note that any investments or portfolio companies referenced in the Materials are illustrative and do not reflect the performance of any Oister Global fund as a whole. There is no obligation for Oister Global to update or alter any forward-looking statements, whether as a result of new information, future events, or otherwise.
PURPOSE LIMITATION AND ACCESS TO YOUR PERSONAL DATA:
We will only collect your personal data in a fair, lawful, and transparent manner. We will keep your personal data accurate and up to date. We will process your personal data in line with your legal rights. We use your name and contact details, such as email, postal address, and contact number to continue communications with you. We may also use your contact information to invite you to events we are hosting or to keep you updated with our news.
USE OF COOKIES OR SIMILAR DEVICES
We use cookies on our website. This helps us to provide you with a better experience when you browse our website and also allows us to make improvements to our site. You may be able to change the preferences on your browser or device to prevent or limit your device’s acceptance of cookies, but this may prevent you from taking advantage of some of our features.
MATERIAL
The material displayed on our site is provided “as is”, without any guarantees, conditions, or warranties as to its accuracy, completeness, or reliability. You should be aware that a significant portion of the Materials includes or consists of information that has been provided by third parties and has not been validated or verified by us. In connection with our investment activities, we often become subject to a variety of confidentiality obligations to funds, investors, portfolio companies, and other third parties. Any statements we make may be affected by those confidentiality obligations, with the result that we may be prohibited from making full disclosures.
MISCELLANEOUS
This Website is operated and controlled by Oister Global in India. We may change the content on our site at any time. If the need arises, we may suspend access to our site, or close it indefinitely. We are under no obligation to update any material on our site.
CONTACT INFORMATION
Any questions, concerns or complaints regarding these Terms should be sent to info@oisterglobal.com
Learn More